<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365772">
  <stage>Registered</stage>
  <submitdate>10/02/2014</submitdate>
  <approvaldate>21/02/2014</approvaldate>
  <actrnumber>ACTRN12614000191695</actrnumber>
  <trial_identification>
    <studytitle>Foot and lower limb complications following the use of extracorporeal membrane oxygenation (ECMO): The FECMO Study. A single centre retrospective observational study.</studytitle>
    <scientifictitle>The FECMO Study: A single centre retrospective observational study/chart audit to determine pre and peri-Extracorporeal membrane oxygenation (ECMO) explanatory variables, and the rates of foot and lower limb complications following the use of ECMO in a major tertiary hospital between 2008-2012. </scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Ischaemia
</healthcondition>
    <healthcondition>Neuropathy</healthcondition>
    <healthcondition>Foot wounds</healthcondition>
    <healthcondition>Foot pressure injuries</healthcondition>
    <healthcondition>Lower limb amputation</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Other skin conditions</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients receiving Extracorporeal membrane oxygenation (ECMO) for respiratory and/or cardiovascular failure. Observing neurovascular status, medications, offloading/pressure relieving stratergies used, foot ulceration/amputation, acute and chronic co-morbidies pre, peri and post (30 days) ECMO intervention. This data is collected via retrospective chart audit for patients receiving intervention between 01/01/2008-31/12/2012.</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To determine Pre &amp; peri-Extracorporeal membrane oxygenation (ECMO) explanatory varibales such as age, gender, BMI, cannulation site, size of cannula, co-morbidities, prescence of H1N1 or H1N2 infection, clinical signs of peripheral lower limb ischaemia, neuropathy &amp;/or wounds pre-ECMO intervention. This will be done via a retrospective chart audit.</outcome>
      <timepoint>Pre-ECMO intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Clinical signs/confirmed diagnosis of peripheral lower limb ischaemia post-ECMO intervention (up to 30 days post intervention) via retrospective chart audit.</outcome>
      <timepoint>30 days post ECMO treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Neuropathy post-ECMO intervention (up to 30 days post intervention) via retrospective chart audit.   </outcome>
      <timepoint>30 days post intervention of ECMO</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Wounds post-ECMO intervention (up to 30 days post intervention) via retrospective chart audit.  </outcome>
      <timepoint>30 days post ECMO treatment.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>30 day mortality post-ECMO intervention (up to 30 days post intervention) via retrospective chart audit.</outcome>
      <timepoint>30 days post ECMO treament</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Participants receiving ECMO from January 2008- December 2012</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients who did not receive ECMO treatment.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>2/01/2013</anticipatedstartdate>
    <actualstartdate>2/01/2013</actualstartdate>
    <anticipatedenddate>31/12/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>55</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>The Prince Charles Hospital - Chermside</hospital>
    <postcode>4032 - Chermside</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>Critical Care Research Group</primarysponsorname>
    <primarysponsoraddress>The Prince Charles Hospital.
MNHHS.
Rode Road,
Chermside.
QLD. 4032.</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>What are the rates of foot and lower limb complications following the use of extracorporeal membrane oxygenation (ECMO) in a major Australian tertiary hospital? Our null hypothesis is that the incidence of foot and lower limb complications in patients undergoing ECMO treatment are not different to those reported in the general inpatient population.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Research, Ethics and Governance Unit</ethicname>
      <ethicaddress>Building 12.
The Prince Charles Hospital.
Rode Road,
Chermside. Qld. 4032.</ethicaddress>
      <ethicapprovaldate>26/08/2011</ethicapprovaldate>
      <hrec>11/QPCH/158</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Helen V Martin</name>
      <address>Podiatry.
Allied Health Department.
The Prince Charles Hospital.
Rode Road,
Chermside.
Qld. 4032.</address>
      <phone>0061 7 3139 5565</phone>
      <fax />
      <email>Helenvictoria.martin@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Helen V Martin</name>
      <address>Podiatry.
Allied Health Department.
The Prince Charles Hospital.
Rode Road,
Chermside.
Qld. 4032.</address>
      <phone>0061 7 3139 5565</phone>
      <fax />
      <email>Helenvictoria.martin@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Helen V Martin</name>
      <address>Podiatry.
Allied Health Department.
The Prince Charles Hospital.
Rode Road,
Chermside.
Qld. 4032.</address>
      <phone>0061 7 3139 5565</phone>
      <fax />
      <email>Helenvictoria.martin@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>